在急性肺损伤期间,由内啡素-2 缺乏引起的炎症活动的急性改善
Ahmad Musthafa1, Gusty Rizky Teguh Ryanto2, Ratoe Suraya3
1Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
The Kobe journal of medical sciences
|November 9, 2023
概括
通过抑制中性粒细胞活动和关键信号通路,Endothelin-2 (Edn2) 删除减少了急性肺损伤 (ALI) 炎症. 针对EDN2可能为ALI提供新的治疗策略.
科学领域:
- 肺部医学 肺部医学
- 炎症研究 炎症研究
- 分子生物学分子生物学
背景情况:
- 急性肺损伤 (ALI) 涉及严重的肺炎,死亡率高,需要新的治疗点.
- 内分泌素-2 (Edn2),一个研究不足的内分泌素异型,在肺生理学中起作用,其信号与炎症途径重叠.
- 内甲素-1 (Edn1) 影响肺炎,这表明Edn2也可能影响ALI病理生理学.
研究的目的:
- 研究Endothelin-2 (Edn2) 在急性肺损伤 (ALI) 炎症中的作用.
- 为了确定Edn2删除是否会影响ALI小鼠模型中的炎症反应.
- 阐明ALI期间Edn2调节的特定分子通路.
主要方法:
- 在条件Edn2淘汰赛 (Edn2-iKO) 小鼠和对照群中使用脂聚糖化物 (LPS) 灌注建立了体内ALI模型.
- 支气管洗液 (BAL) 和肺组织被分析为细胞,分子和组织学炎症标志物.
- 评估了包括IFNγ,STAT1,IL-1β和NFB在内的关键信号通路.
主要成果:
- Edn2-iKO小鼠在ALI中表现出明显减少的亲中性质炎症反应,由BAL液中较低的蛋白质度和中性质细胞数量证明.
- 在Edn2-iKO小鼠中观察到肺干扰素玛 (IFNγ) mRNA水平显著降低.
- 抑制下游信号传输,包括酸化STAT1,IL-1β分泌和NFB激活,在EDn2缺乏的肺部中被检测到.
结论:
- 在小鼠模型中,Endothelin-2 (Edn2) 删除有效地抑制了急性肺炎.
- Edn2删除的抗炎作用是由IFNγ/STAT1/IL-1β/NFB信号级联的下调调的介导.
- 针对EDN2信号提供了一个潜在的治疗策略来管理急性肺损伤.
相关概念视频
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
172
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
172
01:29Acute Respiratory Failure-V
143
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
143
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
190
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
190
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K